Research Article
Prostate Health Index and Prostate Health Index Density as Diagnostic Tools for Improved Prostate Cancer Detection
Table 6
Multivariate logistic regression model analysis predicting the overall and clinically significant prostate cancer.
| Predictors | Overall PCa | Clinically significant PCa | According to Epstein’s criteria | ISUP | Base model | Base model+p2PSA | Base model+%p2PSA | Base model+phi | Base model+PHID | Base model | Base model+p2PSA | Base model+%p2PSA | Base model+phi | Base model+PHID | Base model | Base model+p2PSA | Base model+%p2PSA | Base model+phi | Base model+PHID | OR (95% CI) value | OR (95% CI) value | OR (95% CI) value | OR (95% CI) value | OR (95% CI) value | OR (95% CI) value | OR (95% CI) value | OR (95% CI) value | OR (95% CI) value | OR (95% CI) value | OR (95% CI) P value | OR (95% CI) value | OR (95% CI) value | OR (95% CI) value | OR (95% CI) value |
| Repeated biopsy | 0.44 | 0.34 | 0.44 | 0.37 | 0.37 | — | 0.36 | — | — | — | — | — | — | — | — | (0.20-0.99) | (0.14-0.80) | (0.19-0.99) | (0.16-0.86) | (0.16-0.86) | — | (0.13-0.98) | — | — | — | — | — | — | — | — | 0.048 | 0.013 | 0.048 | 0.021 | 0.019 | >0.05 | 0.046 | >0.05 | >0.05 | >0.05 | >0.05 | >0.05 | >0.05 | >0.05 | >0.05 | PV (mL) | 0.96 | 0.96 | 0.97 | 0.97 | — | 0.96 | 0.96 | 0.96 | 0.97 | — | — | — | — | — | — | (0.95-0.98) | (0.95-0.98) | (0.95-0.98) | (0.95 0.99) | — | (0.94-0.98) | (0.94-0.99) | (0.94-0.99) | (0.95-0.99) | — | — | — | — | — | — | 0.000 | 0.000 | 0.000 | 0.001 | >0.05 | 0.000 | 0.001 | 0.0012 | 0.004 | >0.05 | >0.05 | >0.05 | >0.05 | >0.05 | >0.05 | fPSA (ng/mL) | — | — | — | — | — | 4.38 | — | 6.59 | — | — | — | — | — | — | — | — | — | — | — | — | (1.22-15.71) | — | (1.68-25.97) | — | — | — | — | — | — | — | >0.05 | >0.05 | >0.05 | >0.05 | >0.05 | 0.024 | >0.05 | 0.007 | >0.05 | >0.05 | >0.05 | >0.05 | >0.05 | >0.05 | >0.05 | %fPSA | 0.94 | 0.91 | — | — | — | 0.85 | 0.85 | 0.86 | 0.93 | 0.93 | 0.88 | 0.84 | 0.91 | 0.93 | 0.93 | (0.90-0.99) | (0.86-0.96) | — | — | — | (0.80-0.92) | (0.79-0.91) | (0.80-0.92) | (0.88-0.99) | (0.88-0.99) | (0.82-0.94) | (0.78-0.91) | (0.85-0.98) | (0.86-1.00) | (0.88-0.99) | 0.022 | 0.001 | >0.05 | >0.05 | >0.05 | 0.000 | 0.000 | 0.000 | 0.032 | 0.031 | 0.000 | <0000 | 0.009 | 0.045 | 0.031 | p2PSA (pg/mL) | | 1.10 | | | | | 1.13 | | | | | 1.09 | | | | | (1.03-1.17) | | | | | (1.06-1.22) | | | | | (1.03-1.15) | | | | | 0.003 | | | | | 0.000 | | | | | 0.004 | | | | %p2PSA | | | 2.01 | | | | | 1.95 | | | | | 2.11 | | | | | (1.24-3.27) | | | | | (1.13-3.35) | | | | | (1.27-3.49) | | | | | 0.005 | | | | | 0.016 | | | | | 0.004 | | | phi | | | | 1.05 | | | | | 1.05 | | | | | 1.04 | | | | | (1.02-1.07) | | | | | (1.02-1.08) | | | | | (1.02-1.07) | | | | | | | | | | 0.001 | | | | | 0.002 | | PHID | | | | | 4.34 | | | | | 3.58 | | | | | 2.38 | | | | | (2.52-7.48) | | | | | (2.03-6.30) | | | | | (1.61-3.53) | | | | | 0.000 | | | | | 0.000 | | | | | 0.000 |
|
|
Abbreviations: CI: confidence interval; fPSA: free prostate-specific antigen; ISUP: International Society of Urological Pathology; OR: odds ratio; PCa: prostate cancer; PV: prostate volume; phi: Prostate Health Index; PHID: phi density; tPSA: total PSA; %fPSA: free to total PSA ratio; %p2PSA: p2PSA to fPSA ratio.
|